The resulting proteins are known to function as antagonists within the Tyrosine-protein phosphatase non-receptor type 6 (PTPN6) pathway33 and have been implicated in both, AMD and Alzheimer’s disease risk34. This evidence concerns the gene PTPN6 and Alzheimer disease.